154 related articles for article (PubMed ID: 20678830)
1. Management of oral carcinoma: benefits of early precancerous intervention.
Goodson ML; Thomson PJ
Br J Oral Maxillofac Surg; 2011 Mar; 49(2):88-91. PubMed ID: 20678830
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting carbon dioxide laser treatment for oral precancer: a patient cohort study.
Hamadah O; Thomson PJ
Lasers Surg Med; 2009 Jan; 41(1):17-25. PubMed ID: 19143013
[TBL] [Abstract][Full Text] [Related]
3. Interventional laser surgery: an effective surgical and diagnostic tool in oral precancer management.
Thomson PJ; Wylie J
Int J Oral Maxillofac Surg; 2002 Apr; 31(2):145-53. PubMed ID: 12102411
[TBL] [Abstract][Full Text] [Related]
4. Complications following interventional laser surgery for oral cancer and precancerous lesions.
Goodson ML; Sugden K; Kometa S; Thomson PJ
Br J Oral Maxillofac Surg; 2012 Oct; 50(7):597-600. PubMed ID: 22300551
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of premalignant lesions of the oral cavity with the CO2 laser.
Pinheiro AL; Frame JW
Braz Dent J; 1996; 7(2):103-8. PubMed ID: 9206362
[TBL] [Abstract][Full Text] [Related]
6. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
[TBL] [Abstract][Full Text] [Related]
8. Predicting recurrence after oral precancer treatment: use of cell cycle analysis.
Thomson PJ; Hamadah O; Goodson ML; Cragg N; Booth C
Br J Oral Maxillofac Surg; 2008 Jul; 46(5):370-5. PubMed ID: 18282643
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological behaviour of multiple oral dysplastic lesions compared with that of single lesions.
Hamadah O; Goodson ML; Thomson PJ
Br J Oral Maxillofac Surg; 2010 Oct; 48(7):503-6. PubMed ID: 19800717
[TBL] [Abstract][Full Text] [Related]
10. Use of the laser in the oral cavity.
Burkey MD BB; Garrett G
Otolaryngol Clin North Am; 1996 Dec; 29(6):949-61. PubMed ID: 8890127
[TBL] [Abstract][Full Text] [Related]
11. [A retrospective study of 232 cases of lip cancer and pre cancer in Chilean patients. Clinical-histological correlation].
Ochsenius G; Ormeño A; Godoy L; Rojas R
Rev Med Chil; 2003 Jan; 131(1):60-6. PubMed ID: 12643220
[TBL] [Abstract][Full Text] [Related]
12. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
13. Biopsy and histopathologic diagnosis of oral premalignant and malignant lesions.
Poh CF; Ng S; Berean KW; Williams PM; Rosin MP; Zhang L
J Can Dent Assoc; 2008 Apr; 74(3):283-8. PubMed ID: 18387269
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of head and neck cancer patients referred to an oral and maxillofacial surgeon in the United States for management.
Holmes JD; Martin RA; Gutta R
J Oral Maxillofac Surg; 2010 Mar; 68(3):555-61. PubMed ID: 20171475
[TBL] [Abstract][Full Text] [Related]
15. Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up.
Arduino PG; Surace A; Carbone M; Elia A; Massolini G; Gandolfo S; Broccoletti R
J Oral Pathol Med; 2009 Jul; 38(6):540-4. PubMed ID: 19453839
[TBL] [Abstract][Full Text] [Related]
16. [The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma].
Garozzo A; Cutrona D; Palmeri S; Maiolino L; Puzzo L; Allegra E
Acta Otorhinolaryngol Ital; 1999 Dec; 19(6):342-7. PubMed ID: 10875157
[TBL] [Abstract][Full Text] [Related]
17. Neodymium-YAG and CO2 lasers in treatment of pre-cancerous lesions of the oral cavity.
Gendelman H; Actis AB; Ouri HO
Acta Stomatol Belg; 1993 Jun; 90(2):95-101. PubMed ID: 8237638
[TBL] [Abstract][Full Text] [Related]
18. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up results of Nd: YAG laser treatment of premalignant and malignant (Stage I) squamous cell carcinoma of the oral cavity.
Tewari M; Rai P; Singh GB; Kumar M; Shukla HS
J Surg Oncol; 2007 Mar; 95(4):281-5. PubMed ID: 17326123
[TBL] [Abstract][Full Text] [Related]
20. Management of oral squamous cell carcinoma treated with inadequate excisional biopsy.
Bailey JS; Blanchaert RH; Ord RA
J Oral Maxillofac Surg; 2001 Sep; 59(9):1007-10; discussion 1011. PubMed ID: 11526566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
